Loading
Life sciences · Journal article
Medicine International · September 8, 2026
Raises a question worth testing. It does not answer one.
This is a descriptive overview introducing the Tamaru Method Plasma Therapy, a proposed non-invasive system combining a plasma-generating device with oral plasma-activated water intake. The source outlines hypothesized mechanisms—intracellular ATP enhancement and nitric oxide generation—but presents no human efficacy data, clinical outcomes, or comparative evidence to support therapeutic claims.
Journal article. Implicit: cancer patients in Japan; no actual enrolled population described.. Intervention: Tamaru Method Plasma Therapy: Plasma AIAS device combined with oral plasma-activated water intake. Japan (implied context only).
NEAPP (non-equilibrium atmospheric pressure plasma) proposed as emerging modality in oncology Established approaches (direct irradiation and plasma-activated medium) reported to induce apoptosis in malignant cells Tamaru Method combines Plasma AIAS device with oral plasma-activated water intake
No safety, tolerability, or adverse event data provided
This work presents a conceptual framework and theoretical rationale for a novel treatment approach but contains no clinical trial data, efficacy measurements, or safety outcomes. Clinicians should not alter practice based on this overview; it describes a hypothesis requiring formal human evaluation.
This is a descriptive overview of mechanistic principles and a novel uncontrolled therapeutic system without comparative efficacy data, clinical outcomes, or human trial results.
As stated by the source record.
This work presents a conceptual framework and theoretical rationale for a novel treatment approach but contains no clinical trial data, efficacy measurements, or safety outcomes. Clinicians should not alter practice based on this overview; it describes a hypothesis requiring formal human evaluation.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
the rapid aging of the population in Japan has led to an increased incidence of cancer, creating a demand for effective therapeutic options with minimal physical and financial burden.Non-equilibrium atmospheric pressure plasma (NEAPP), or low-temperature plasma, has emerged as a promising modality in oncology.The present study summarizes the fundamental principles of NEAPP and its therapeutic applications in cancer treatment.The authors first provide an overview of established approaches, such as the direct irradiation of cancer cells and the indirect use of plasma-activated medium, which have been shown to induce apoptosis in malignant cells.Subsequently, the authors introduce a novel therapeutic system, the tamaru Method Plasma Therapy, developed by the authors' research group.This system combines a unique plasma-generating device, termed Plasma AIAS, with the oral intake of plasma-activated water.The proposed mechanism of this non-invasive method is the systemic enhancement of intracellular adenosine triphosphate production and the generation of nitric oxide.This dual action is expected to improve microcirculation and exert anti-tumor effects, while maintaining a high safety profile.The present study highlights the potential of this original method as a next-generation therapy for cancer, addressing the needs of modern medical care.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.